These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6372801)

  • 1. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
    Berg D; Regel E; Harenberg HE; Plempel M
    Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifonazole, a biochemist's view.
    Berg D; Plempel M
    Dermatologica; 1984; 169 Suppl 1():3-9. PubMed ID: 6396116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
    Shadomy S; Dixon DM; May R
    Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
    Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Light and scanning electron microscopy.
    Barug D; Samson RA; Kerkenaar A
    Arzneimittelforschung; 1983; 33(4):528-37. PubMed ID: 6347209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae.
    Berg D; Draber W; von Hugo H; Hummel W; Mayer D
    Z Naturforsch C Biosci; 1981; 36(9-10):798-803. PubMed ID: 7029940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
    Haller I
    Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of two benzofuran-imidazoles in different experimental conditions.
    Bellotti MG; Dubini F; Riviera L; Pestellini V
    J Chemother; 1991 Oct; 3(5):295-304. PubMed ID: 1809809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
    Spiekermann PH; Young MD
    Arch Dermatol; 1976 Mar; 112(3):350-2. PubMed ID: 769697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis.
    Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes DC; Estivill D; Giusiano G
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4420-1. PubMed ID: 21746955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes].
    Yamaguchi H; Uchida K; Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Kubo M; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
    Jpn J Antibiot; 1996 Dec; 49(12):1085-94. PubMed ID: 9032595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Freeze fracture electron microscopy.
    Barug D; de Groot C
    Arzneimittelforschung; 1983; 33(4):538-45. PubMed ID: 6347210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1007-12. PubMed ID: 1960850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of clotrimazole (Bay b 5097).
    Shadomy S
    Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.
    Wächtler B; Wilson D; Hube B
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4436-9. PubMed ID: 21746947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of susceptibility of dermatophytes to antifungal drugs].
    Macura AB; Filip E; Pawlik B
    Med Dosw Mikrobiol; 1993; 45(2):253-7. PubMed ID: 8309309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lethal action of 1,10-phenanthroline transition metal chelates and related compounds on dermatophytes and Candida albicans.
    Shulman A; Cade G; Dumble L; Laycock GM
    Arzneimittelforschung; 1972 Jan; 22(1):154-8. PubMed ID: 4552248
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimycotic efficacy of bifonazole in vitro and in vivo.
    Plempel M; Regel E; Büchel KH
    Arzneimittelforschung; 1983; 33(4):517-24. PubMed ID: 6683530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.